Authum Investment Acquires 35.09% Stake in Rivaara Labs for Rs. 36,56,83,001

Authum Investment & Infrastructure Ltd has entered into a binding agreement to acquire 35.09% stake in Rivaara Labs Private Limited. The total cost of acquisition is Rs. 36,56,83,001, which includes a primary infusion of Rs. 36,00,00,000 and a purchase consideration of Rs. 56,83,001. Post-acquisition, Authum will hold 7,69,88,011 CCPS and 1,58,42,000 equity shares of Rivaara Labs. Rivaara Labs is engaged in the business of diagnostic services, distribution of diagnostic kits, and digital healthcare products. The acquisition is expected to be completed by September 30, 2025, subject to the fulfillment of certain conditions precedent.